World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases

Datavault AI Inc. (NASDAQ: DVLT) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

Cision PR Newswire by Cision PR Newswire
September 25, 2026
in Press Releases
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

PHILADELPHIA, Sept. 25, 2026 /PRNewswire/ — National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against Datavault AI Inc. (NASDAQ: DVLT) (“Datavault” or the “Company”) on behalf of investors who purchased or acquired Datavault securities during the period from September 4, 2024 through October 30, 2025 (the “Class Period”).

A national class action and commercial litigation law firm with nationally known attorneys highly sought after for their legal skills. (PRNewsFoto/Berger Montague)

Investor Deadline: Investors who purchased or acquired Datavault securities during the Class Period may, no later than October 5, 2026, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE.

The Company, headquartered in Philadelphia, PA, is a technology company focused on AI, data monetization, and the Datavault Platform.

According to the lawsuit, during the Class Period, Datavault overstated the economic value of its partnerships with Burke Products, Scilex Holding Company, and Nature’s Miracle Holding Inc., while also overstating the volume of trading activity on the Datavault Platform.

The suit further alleges that the Company failed to disclose its connections to convicted felon Edward Withrow III and that those undisclosed affiliations, together with CEO Nathaniel T. Bradley’s prior SEC charges, created material reputational risks.

On October 31, 2025, Wolfpack Research published a report alleging that Datavault misled investors regarding its AI, quantum computing, Web3, and data monetization. According to the report, the Company’s partnerships could not provide the economic upside represented by Defendants, the Datavault Platform had virtually no trading activity, and the Company’s leadership had undisclosed regulatory and criminal associations.

On this news, Datavault shares declined $0.49 per share, or 19%, from a closing price of $2.52 per share on October 30, 2025, to close at $2.03 per share on October 31, 2025.

If you are a Datavault investor and would like to learn more about this action, CLICK HERE or please contact Berger Montague: Andrew Abramowitz at aabramowitz@bergermontague.com or (215) 875-3015, or Caitlin Adorni at cadorni@bergermontague.com or (267) 764-4865.

About Berger Montague

Berger Montague is one of the nation’s preeminent law firms focusing on complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law, employment law, securities, and whistleblower cases, among many other practice areas. For over 55 years, Berger Montague has played leading roles in precedent-setting cases and has recovered over $50 billion for its clients and the classes they have represented. Berger Montague is headquartered in Philadelphia and has offices in Chicago; Malvern, PA; Minneapolis; San Diego; San Francisco; Toronto, Canada; Washington, D.C., and Wilmington, DE.

For more information or to discuss your rights, please contact:

Andrew Abramowitz
Berger Montague
(215) 875-3015
aabramowitz@bergermontague.com

Caitlin Adorni
Berger Montague
(267) 764-4865
cadorni@bergermontague.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/datavault-ai-inc-nasdaq-dvlt-deadline-approaching-berger-montague-advises-investors-of-deadline-in-securities-fraud-lawsuit-302889930.html

SOURCE Berger Montague

Cision PR Newswire

Cision PR Newswire

Related Posts

NJASAP Applauds Senate for Passage of Aeromedical Reform Measures

September 25, 2026

Former RESTORE Council Chief Scientist Appointed to Federal Hunting and Conservation Advisory Council

September 25, 2026

Bronstein, Gewirtz & Grossman LLC Urges Better Home & Finance Holding Company Investors to Act: Class Action Filed Alleging Investor Harm

September 25, 2026

UPDATE: Bird&Be Featured in Consumer Reports’ Prenatal Vitamin Testing

September 25, 2026

Hims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit

September 25, 2026

2026 IMS | IASO Bio Presents First-in-Human Phase 1 Data of RD140, a Fully Human BCMA/GPRC5D Dual-Targeted FasT CAR-T

September 25, 2026

Popular News

  • NJASAP Applauds Senate for Passage of Aeromedical Reform Measures

    0 shares
    Share 0 Tweet 0
  • Former RESTORE Council Chief Scientist Appointed to Federal Hunting and Conservation Advisory Council

    0 shares
    Share 0 Tweet 0
  • Datavault AI Inc. (NASDAQ: DVLT) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

    0 shares
    Share 0 Tweet 0
  • Bronstein, Gewirtz & Grossman LLC Urges Better Home & Finance Holding Company Investors to Act: Class Action Filed Alleging Investor Harm

    0 shares
    Share 0 Tweet 0
  • UPDATE: Bird&Be Featured in Consumer Reports’ Prenatal Vitamin Testing

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler